Skip to content
Law and legal tech, in three minutesGet the 7 a.m. briefDaily Brief PodcastMenu

Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.

AnnouncementAnnounced by Sidley Austin · · summarized by LexCircuit Desk

Sidley says it represented Pyxis Oncology in a public offering

Sidley said it represented Pyxis Oncology in an underwritten offering of common stock, pre-funded warrants and accompanying common warrants. The firm said expected gross proceeds were approximately $110 million, with up to another $172.6 million possible if the warrants are exercised in full.

Key points

  • Sidley described Pyxis as a clinical-stage biotechnology company developing cancer therapeutics.Sidley
  • The firm said Asher Rubin and Istvan Hajdu led its team.Sidley
  • Sidley said Henry Dickinson and Eric Carlson advised on capital markets matters.Sidley
  • The firm said its team also included regulatory and tax lawyers.Sidley
Sidley · Sidley Austin LLP

The announcement

Firm